HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.

351 Clinical Trials
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / IND29934-AR

IND 29934 – Single Patient Emergency Use IND of Brexucabtagene Autoleucel in Patient AR

Learn More
Bone Marrow Transplant Phase III Enrolling
nct/study# NCT06585774 / INCA34176-357

Phase 3 Study of Axatilimab (INCA034176) and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease (INCA34176-357).

Learn More
Bone Marrow Transplant Phase III Enrolling
nct/study# NCT04293185 / HGB210-JTCC

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Sickle Cell Disease

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / GVHD-ROSENSTEIN

Biomarkers and Pathogenesis of Cutaneous Fibrosis

Learn More
Bone Marrow Transplant Phase II Enrolling
nct/study# NCT07214688 / FLU-TBI-800-PTCY

A Phase 2 Study of Fludarabine and Intermediate Dose Total Body Irradiation (800 cGy) Followed by Post-Transplant Cyclophosphamide in Patients Aged 18-65 Undergoing Allogeneic Stem Cell Transplant for Hematologic Malignancies

Learn More
Bone Marrow Transplant Phase I Enrolling
nct/study# NCT03909412 / ISS-20159907

Phase I Study of Carfilzomib-based Chemotherapy Mobilization for Autologous Stem Cell Transplantation in Multiple Myeloma

Learn More

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.